From the Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom (Neo); The Royal College of Ophthalmologists' National Ophthalmology Audit, London, United Kingdom (Gruszka-Goh, Donachie, Buchan); Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, United Kingdom (Gruszka-Goh, Donachie); Worcestershire Acute Hospitals NHS Trust, Worchester, United Kingdom (Braga); Manchester University NHS Foundation Trust, Manchester, United Kingdom (de Klerk); Royal Surrey NHS Foundation Trust, Guildford, United Kingdom (Lindfield); Northern Devon Healthcare NHS Trust, Devon, United Kingdom (Nestel); Belfast Health and Social Care Trust, Belfast, United Kingdom (Stewart); Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom (Stewart); International Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, United Kingdom (Buchan); Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom (Buchan).

Corresponding author: John C. Buchan, FRCOphth, MD, International Centre for Eye Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom. Email: [email protected].

The National Cataract Audit is currently funded through participation fees from centers and unrestricted financial contributions from Alcon Laboratories, Inc. and Bausch & Lomb, Inc.

Presented at the 41st Congress of the ESCRS, Milan, Italy, September 2022.

Disclosures: None of the authors have any financial or proprietary interest in any material or method mentioned.

First author:Yan Ning Neo, FRCOphth, FEBOMoorfields Eye Hospital NHS Foundation Trust, London, United Kingdom